Matching articles for "bisacodyl"
Issue 1675 · May 1, 2023
Vibrant – An Oral Vibrating Capsule for Chronic Idiopathic Constipation

The Vibrant orally administered vibrating capsule (Vibrant Gastro), an FDA-cleared medical device, is now available by prescription for treatment of adults with chronic idiopathic constipation (CIC) who have…

Med Lett Drugs Ther. 2023 May 1; 65(1675):65-7 doi:10.58347/tml.2023.1675a
The Vibrant orally administered vibrating capsule (Vibrant Gastro), an FDA-cleared medical device, is now available by prescription for treatment of adults with chronic idiopathic constipation (CIC) who have not experienced relief of their bowel symptoms by using laxative therapies at the recommended dosage for at least one month. It is the first drug-free treatment to be authorized by the FDA for this indication.
Issue 1573 · June 3, 2019
Prucalopride (Motegrity) for Chronic Idiopathic Constipation

The FDA has approved the 5-HT4 receptor agonist prucalopride ( Motegrity – Shire) for treatment of chronic idiopathic constipation (CIC) in adults. Prucalopride is the only drug currently approved in the US…

Med Lett Drugs Ther. 2019 Jun 3; 61(1573):86-8
The FDA has approved the 5-HT4 receptor agonist prucalopride ( Motegrity – Shire) for treatment of chronic idiopathic constipation (CIC) in adults. Prucalopride is the only drug currently approved in the US for treatment of CIC that stimulates colonic peristalsis. It has been available in Europe and Canada for several years.
Issue 1564 · January 28, 2019
Plenvu - A Low-Volume PEG-Based Colonoscopy Preparation

The FDA has approved Plenvu (Salix), a polyethylene glycol (PEG)-containing oral powder for reconstitution, for colon cleansing prior to colonoscopy in adults. Plenvu is the first PEG-containing colonoscopy…

Med Lett Drugs Ther. 2019 Jan 28; 61(1564):11-4
The FDA has approved Plenvu (Salix), a polyethylene glycol (PEG)-containing oral powder for reconstitution, for colon cleansing prior to colonoscopy in adults. Plenvu is the first PEG-containing colonoscopy preparation that requires only 1 L of water for dissolution and ingestion of 1 L of clear fluid in addition.
Issue 1547 · May 21, 2018
Clenpiq - A Low-Volume Sodium Picosulfate-Based Colonoscopy Preparation

The FDA has approved Clenpiq (Ferring), a low-volume oral solution that contains sodium picosulfate, magnesium oxide, and anhydrous citric acid, for colon cleansing prior to colonoscopy in adults. The…

Med Lett Drugs Ther. 2018 May 21; 60(1547):84-6
The FDA has approved Clenpiq (Ferring), a low-volume oral solution that contains sodium picosulfate, magnesium oxide, and anhydrous citric acid, for colon cleansing prior to colonoscopy in adults. The ready-to-drink solution contains the same ingredients as Prepopik , which is supplied as a powder for reconstitution.
Issue 1519 · April 24, 2017
Plecanatide (Trulance) for Chronic Idiopathic Constipation

The FDA has approved plecanatide ( Trulance – Synergy), a guanylate cyclase-C receptor agonist, for treatment of chronic idiopathic constipation (CIC) in adults. Linaclotide (Linzess) , another guanylate…

Med Lett Drugs Ther. 2017 Apr 24; 59(1519):66-8
The FDA has approved plecanatide ( Trulance – Synergy), a guanylate cyclase-C receptor agonist, for treatment of chronic idiopathic constipation (CIC) in adults. Linaclotide (Linzess) , another guanylate cyclase-C receptor agonist, and lubiprostone (Amitiza) , a chloride channel activator, were approved earlier for treatment of CIC in adults.
Issue 1408 · January 21, 2013
Colonoscopy Preparations

Colonoscopy remains the preferred method of colorectal cancer screening. Many patients consider cleansing the bowel in preparation for colonoscopy the most unpleasant part of the procedure, but inadequate…

Med Lett Drugs Ther. 2013 Jan 21; 55(1408):6-7
Colonoscopy remains the preferred method of colorectal cancer screening. Many patients consider cleansing the bowel in preparation for colonoscopy the most unpleasant part of the procedure, but inadequate bowel preparation significantly lowers the diagnostic yield.
Issue 107 · July 1, 2011
Drugs for Irritable Bowel Syndrome

Irritable bowel syndrome (IBS) is a common disorder, occurring in up to 15% of the US population; it is 2-2.5 times more frequent in women than in men. IBS is characterized by chronic, intermittent abdominal…

Treat Guidel Med Lett. 2011 Jul; 9(107):41-6
Irritable bowel syndrome (IBS) is a common disorder, occurring in up to 15% of the US population; it is 2-2.5 times more frequent in women than in men. IBS is characterized by chronic, intermittent abdominal pain or discomfort accompanied by altered bowel habits. Since the underlying mechanisms of disease remain unclear, management of IBS focuses on symptom control.
Issue 1362 · April 18, 2011
A New Testosterone Gel (Fortesta) for Hypogonadism

The FDA has approved Fortesta (Endo), a topical gel, for testosterone replacement therapy in adult males with hypogonadism. It is classified as a Schedule III controlled substance. Table 1 lists some available…

Med Lett Drugs Ther. 2011 Apr 18; 53(1362):29-30
The FDA has approved Fortesta (Endo), a topical gel, for testosterone replacement therapy in adult males with hypogonadism. It is classified as a Schedule III controlled substance. Table 1 lists some available testosterone products, including 2 other gels.
Issue 43 · March 1, 2006
Drugs for Irritable Bowel Syndrome

Irritable bowel syndrome (IBS) is a common disorder, occuring in about 15% of the US population; it is 2-3 times more frequent in women than in men. IBS is characterized by chronic abdominal pain or discomfort…

Treat Guidel Med Lett. 2006 Mar; 4(43):11-6
Irritable bowel syndrome (IBS) is a common disorder, occuring in about 15% of the US population; it is 2-3 times more frequent in women than in men. IBS is characterized by chronic abdominal pain or discomfort and altered bowel habits.
Issue 1220 · October 24, 2005 Free
Colonoscopy Preps Addendum

Since the publication of our article on colonoscopy preparations, 1 which compared polyethylene glycol electrolyte solutions ( GoLytely , and others) with sodium phosphate ( Fleet Phospho-Soda , and others),…

Med Lett Drugs Ther. 2005 Oct 24; 47(1220):88
Since the publication of our article on colonoscopy preparations, 1 which compared polyethylene glycol electrolyte solutions ( GoLytely , and others) with sodium phosphate ( Fleet Phospho-Soda , and others), some readers have told us that we should have included a combination of a magnesium citrate solution with bisacodyl tablets ( Evac -QKwik, and others) as an alternative. In one study, such a preparation offered better cleansing and patient tolerance than a sodium phosphate regimen. 2 1. Colonoscopy preparations. Med Lett Drugs Ther 2005; 47:53. 2. M Delegge and R Kaplan. Efficacy of bowel preparation with the use of a prepackaged, low fibre diet with a low sodium, magnesium citrate cathartic vs. a clear liquid diet with a standard sodium phosphate cathartic. Aliment Pharmacol Ther 2005; 21:1491.
Issue 1212 · July 4, 2005
Colonoscopy Preparations

Many patients consider cleansing the bowel in preparation for colonoscopy the most unpleasant part of the procedure. Several methods are available.

Med Lett Drugs Ther. 2005 Jul 4; 47(1212):53-4
Many patients consider cleansing the bowel in preparation for colonoscopy the most unpleasant part of the procedure. Several methods are available.